Literature DB >> 21227691

Inhibitory effects of ethacrynic acid analogues lacking the α,β-unsaturated carbonyl unit and para-acylated phenols on human cancer cells.

Zack E Bryant1, Romy F J Janser, Medina Jabarkhail, Melissa S Candelaria-Lyons, Brittni B Romero, Severine Van slambrouck, Wim F A Steelant, Ingo Janser.   

Abstract

A series of ethacrynic acid analogues, lacking the α,β-unsaturated carbonyl unit, was synthesized and subsequently evaluated for their ability to inhibit the migration of human breast cancer cells, Hs578Ts(i)8 as well as of human prostate cancer cells, C4-2B. These cell lines provide a good model system to study migration and invasion, since they represent metastatic cancer. Our studies show that ethacrynic acid analogues with methyl substituents at the aromatic ring demonstrate no inhibitory effect on the migration of both cancer cell lines, whereas a precursor in the synthesis of these ethacrynic acid analogues (II-1, a para-acylated m-cresol) is an excellent inhibitor of the migration of both cancer cell lines.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21227691      PMCID: PMC3057390          DOI: 10.1016/j.bmcl.2010.12.074

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  18 in total

Review 1.  Non-peptidic inhibitors of cysteine proteases.

Authors:  T Schirmeister; U Kaeppler
Journal:  Mini Rev Med Chem       Date:  2003-06       Impact factor: 3.862

2.  A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods.

Authors:  Ulrich Kaeppler; Nikolaus Stiefl; Markus Schiller; Radim Vicik; Alexander Breuning; Werner Schmitz; Daniel Rupprecht; Carsten Schmuck; Knut Baumann; John Ziebuhr; Tanja Schirmeister
Journal:  J Med Chem       Date:  2005-11-03       Impact factor: 7.446

3.  Selective toxicity of ethacrynic acid towards lymphocytes of chronic lymphocytic leukemia in vitro.

Authors:  P R Twentyman; E Lambert; M Müller; J K Rees
Journal:  Leukemia       Date:  1992-07       Impact factor: 11.528

Review 4.  Advance in antitumor agents targeting glutathione-S-transferase.

Authors:  Guisen Zhao; Xiaobing Wang
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

5.  Synthesis and structure-activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition.

Authors:  Guisen Zhao; Tao Yu; Rui Wang; Xiaobing Wang; Yongkui Jing
Journal:  Bioorg Med Chem       Date:  2005-06-02       Impact factor: 3.641

Review 6.  Inhibitors of cysteine proteases.

Authors:  Radim Vicik; Matthias Busemann; Knut Baumann; Tanja Schirmeister
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

7.  Inhibition of glutathione S-transferase activity in human melanoma cells by alpha,beta-unsaturated carbonyl derivatives. Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal.

Authors:  M L Iersel; J P Ploemen; I Struik; C van Amersfoort; A E Keyzer; J G Schefferlie; P J van Bladeren
Journal:  Chem Biol Interact       Date:  1996-10-21       Impact factor: 5.192

8.  Novel oxadiazole analogues derived from ethacrynic acid: design, synthesis, and structure-activity relationships in inhibiting the activity of glutathione S-transferase P1-1 and cancer cell proliferation.

Authors:  Xinmei Yang; Guyue Liu; Hongcai Li; Yun Zhang; Dandan Song; Chunmin Li; Rui Wang; Bo Liu; Wen Liang; Yongkui Jing; Guisen Zhao
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

9.  Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine.

Authors:  Shu Aizawa; Keizou Ookawa; Toshihiro Kudo; Junpei Asano; Makoto Hayakari; Shigeki Tsuchida
Journal:  Cancer Sci       Date:  2003-10       Impact factor: 6.716

10.  AsialoGM1 and integrin alpha2beta1 mediate prostate cancer progression.

Authors:  Severine Van Slambrouck; John Hilkens; Marco Bisoffi; Wim F A Steelant
Journal:  Int J Oncol       Date:  2009-10       Impact factor: 5.650

View more
  2 in total

1.  Selective methoxy ether cleavage of 2,6-dimethoxyphenol followed by a selective acylation.

Authors:  Enoch A Adogla; Romy F J Janser; Samuel S Fairbanks; Caitlyn M Vortolomei; Ranjith K Meka; Ingo Janser
Journal:  Tetrahedron Lett       Date:  2012-01-04       Impact factor: 2.415

2.  Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer.

Authors:  Bing Liu; XinPing Huang; YunLong Hu; TingTing Chen; BoYa Peng; NingNing Gao; ZhenChao Jin; TieLiu Jia; Na Zhang; ZhuLin Wang; GuangYi Jin
Journal:  Oncotarget       Date:  2016-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.